AKR1B10 and viral infectious disease: More investigations are needed to monitor the AKR1B10 expression kinetics during COVID-19 disease progression in order to determine if the high AKR1B10 expression detected in the lungs and blood of patients is also observed prior to the viral infection, in which case its dosage in the sera could be a risk predictor of severe COVID-19 forms.